Peregrine System Kit
Phase 3- Indications
- Uncontrolled hypertension
Company intelligence / Profile preview
Ablative Solutions
Kalamazoo, Michigan, USAablativesolutions.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
The Peregrine System™ has demonstrated positive results in pivotal clinical trials for uncontrolled hypertension. Two randomized sham-controlled trials—TARGET BP OFF-MED and TARGET BP I—have been conducted. The company has reported meeting primary endpoints and positive long-term data from post-market studies. The procedure provides deep circumferential ablation of renal nerves with a minimally invasive approach using dehydrated alcohol delivered via catheter. Not yet FDA approved but CE Marked for use in Europe.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceSmall molecule (dehydrated alcohol)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
BioStar VenturesGilde Healthcare (investors/partners supporting development)
Beyond the preview
Go deeper on Ablative Solutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ablative Solutions.